Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Emma Andrade
Observed name:
E.L. Andrade
Institution:
California State University, Fresno
Observed institutions:
California State University, Fresno,
Universidad Nacional Autónoma de México
OpenAlex ID:
A5005184635
Non-clinical studies in the process of new drug development - Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies
2016
·
E.L. Andrade
, A.F. Bento
, et al.
·
Brazilian Journal of Medical and Biological Research
·
222
PDF
Non-clinical studies required for new drug development - Part I: early in silico and in vitro studies, new target discovery and validation, proof of principles and robustness of animal studies
2016
·
E.L. Andrade
, A.F. Bento
, et al.
·
Brazilian Journal of Medical and Biological Research
·
99
PDF
Bridging informatics and medicinal inorganic chemistry: Toward a database of metallodrugs and metallodrug candidates
2022
·
José L. Medina-Franco
, Edgar López-López
, et al.
·
Drug Discovery Today
·
39
User-Item Recommendation Approaches to Detect Genomic Variant Interactions
2022
·
Emma Andrade
, Nicholas Tom
, et al.
·
Asia-Pacific Signal and Information Processing Association Annual Summit and Conference (APSIPA ASC)
·
1
Recommendation and Clustering Methods for Quantifying Genomic Signal Interactions
2023
·
Sarah Garner
, Mario Banuelos
, et al.
·
International symposium on image and signal processing and analysis/ISPA ...
Non-clinical studies in the process of new drug development - Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies
2019
·
E.L. Andrade
, A.F. Bento
, et al.
·
Figshare
Show more works
View as search
Works count:
6
Citation count:
361
H-index:
3
I10-index:
3
Year
Topic
Type